Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $3,190 | 11 | 65.0% |
| Food and Beverage | $1,509 | 55 | 30.7% |
| Entertainment | $198.18 | 1 | 4.0% |
| Education | $12.08 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,329 | 11 | $0 (2018) |
| Stryker Corporation | $1,354 | 8 | $0 (2024) |
| Abbott Laboratories | $570.66 | 22 | $0 (2024) |
| Nevro Corp. | $218.62 | 10 | $0 (2023) |
| BIONESS INC | $198.18 | 1 | $0 (2019) |
| SPR Therapeutics, Inc | $34.98 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $30.21 | 1 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $24.95 | 2 | $0 (2019) |
| CooperSurgical, Inc. | $21.43 | 2 | $0 (2019) |
| Vertical Pharmaceuticals, LLC | $18.45 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $163.15 | 7 | Stryker Corporation ($50.13) |
| 2023 | $13.72 | 1 | Nevro Corp. ($13.72) |
| 2022 | $97.96 | 5 | Abbott Laboratories ($67.66) |
| 2021 | $12.08 | 1 | Almatica Pharma LLC ($12.08) |
| 2020 | $62.99 | 2 | Abbott Laboratories ($62.99) |
| 2019 | $1,768 | 22 | Stryker Corporation ($1,304) |
| 2018 | $2,668 | 23 | Boston Scientific Corporation ($2,311) |
| 2017 | $122.15 | 7 | Nevro Corp. ($67.38) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $34.98 | General |
| Category: Pain management | ||||||
| 12/19/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 08/06/2024 | Stryker Corporation | MULTIGEN 2 (Device) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 06/12/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Neuromodulation | ||||||
| 06/03/2024 | Stryker Corporation | MULTIGEN 2 (Device) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 05/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: PSYCHIATRY | ||||||
| 01/18/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $7.06 | General |
| Category: Spinal Cord Stimulator | ||||||
| 02/09/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/14/2022 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Neuromodulation | ||||||
| 11/04/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/12/2022 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Neuromodulation | ||||||
| 07/12/2022 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Neuromodulation | ||||||
| 04/14/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2021 | Almatica Pharma LLC | GRALISE (Drug) | Education | In-kind items and services | $12.08 | General |
| Category: POSTHERPETIC NEURALGIA | ||||||
| 04/20/2020 | Abbott Laboratories | Octrode SCS Leads (Device) | Food and Beverage | In-kind items and services | $43.11 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 01/08/2020 | Abbott Laboratories | Octrode SCS Leads (Device) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 12/20/2019 | Abbott Laboratories | Octrode SCS Leads (Device) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 12/16/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2019 | Abbott Laboratories | Octrode SCS Leads (Device) | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 10/28/2019 | Stryker Corporation | IVS - VERTEBRAL AUGMENTATION PRODUCTS (Device) | Travel and Lodging | Cash or cash equivalent | $333.50 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 10/06/2019 | Stryker Corporation | IVS - VERTEBRAL AUGMENTATION PRODUCTS (Device) | Travel and Lodging | Cash or cash equivalent | $358.00 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 10/05/2019 | Stryker Corporation | IVS - VERTEBRAL AUGMENTATION PRODUCTS (Device) | Food and Beverage | Cash or cash equivalent | $44.32 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 10/05/2019 | Stryker Corporation | IVS - VERTEBRAL AUGMENTATION PRODUCTS (Device) | Food and Beverage | Cash or cash equivalent | $30.68 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 10/02/2019 | Stryker Corporation | IVS - VERTEBRAL AUGMENTATION PRODUCTS (Device) | Travel and Lodging | Cash or cash equivalent | $168.73 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 09/30/2019 | CooperSurgical, Inc. | Endosee (Device) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 458 | 878 | $964,618 | $73,604 |
| 2022 | 21 | 820 | 1,831 | $1.6M | $118,505 |
| 2021 | 23 | 901 | 2,194 | $1.8M | $139,981 |
| 2020 | 24 | 928 | 2,362 | $2.1M | $158,384 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 49 | 89 | $183,963 | $12,955 | 7.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 120 | $24,816 | $10,344 | 41.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 33 | 89 | $162,426 | $9,521 | 5.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $12,572 | $5,213 | 41.5% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 17 | 34 | $71,060 | $4,996 | 7.0% |
| 64640 | Destruction of peripheral nerve or branch | Facility | 2023 | 15 | 73 | $90,009 | $4,047 | 4.5% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 18 | 46 | $59,248 | $3,770 | 6.4% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 44 | 79 | $67,150 | $3,551 | 5.3% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 19 | 36 | $57,821 | $3,482 | 6.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 17 | 37 | $47,101 | $2,811 | 6.0% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 12 | 23 | $40,807 | $2,619 | 6.4% |
| 64451 | Injection of anesthetic agent and/or steroid into spine and pelvis nerve using imaging guidance | Facility | 2023 | 11 | 19 | $42,560 | $1,788 | 4.2% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 17 | 34 | $31,722 | $1,746 | 5.5% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 13 | 23 | $3,807 | $1,658 | 43.6% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 15 | 39 | $23,362 | $1,643 | 7.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 15 | 29 | $24,864 | $1,602 | 6.4% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 12 | 23 | $20,551 | $1,481 | 7.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 17 | 21 | $469.00 | $259.35 | 55.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 13 | 20 | $310.00 | $116.33 | 37.5% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 77 | 141 | $291,447 | $20,496 | 7.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 50 | 138 | $254,232 | $14,840 | 5.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 161 | $28,658 | $13,488 | 47.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 55 | 112 | $175,189 | $10,729 | 6.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 73 | 73 | $19,783 | $8,212 | 41.5% |
| 64640 | Destruction of peripheral nerve or branch | Facility | 2022 | 29 | 155 | $191,115 | $8,070 | 4.2% |
About Dr. Deepesh Shah, MD
Dr. Deepesh Shah, MD is a Anesthesiology healthcare provider based in Glendale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1558548735.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepesh Shah, MD has received a total of $4,909 in payments from pharmaceutical and medical device companies, with $163.15 received in 2024. These payments were reported across 68 transactions from 19 companies. The most common payment nature is "Travel and Lodging" ($3,190).
As a Medicare-enrolled provider, Shah has provided services to 3,107 Medicare beneficiaries, totaling 7,265 services with total Medicare billing of $490,474. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine, Specialist
- Location Glendale, AZ
- Active Since 01/30/2008
- Last Updated 09/13/2024
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1558548735
Products in Payments
- SPECTRA WAVEWRITER (Device) $1,545
- IVS - VERTEBRAL AUGMENTATION PRODUCTS (Device) $1,304
- PRECISION (Device) $765.20
- Octrode SCS Leads (Device) $204.21
- Stimrouter for pain (Device) $198.18
- Senza Spinal Cord Stimulation System (Device) $192.80
- NT1100 NT2000iX Simplicity (Device) $159.33
- OCTRODE (Device) $67.66
- MULTIGEN 2 (Device) $50.13
- Neuromodulation Dspsbls and Accs (Device) $43.89
- SPRINT PNS System (Device) $34.98
- REXULTI (Drug) $30.21
- Protege Family of SCS IPGs (Device) $25.93
- RELISTOR (Drug) $24.95
- ETERNA (Device) $24.66
- Prodigy Family of SCS IPGs (Device) $19.53
- SCS leads (Device) $18.63
- GENERAL - PAIN MANAGEMENT (Device) $18.50
- LORZONE (Drug) $18.45
- UBRELVY (Drug) $18.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Glendale
Christopher Charbonnet, M.d, M.D
Anesthesiology — Payments: $10,665
Dr. Omar Syed, M.d, M.D
Anesthesiology — Payments: $9,133
Robin Kim, M.d, M.D
Anesthesiology — Payments: $7,188
Dr. Brian Page, Do, DO
Anesthesiology — Payments: $6,381
Taell Kim, M.d, M.D
Anesthesiology — Payments: $5,604
Dr. James Nassiri, Md, Ma, MD, MA
Anesthesiology — Payments: $4,172